Cargando…
Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
BACKGROUND: Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. METHODS: Bu...
Autores principales: | Yano, Junko, Sobel, Jack D., Nyirjesy, Paul, Sobel, Ryan, Williams, Valerie L., Yu, Qingzhao, Noverr, Mairi C., Fidel, Paul L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441174/ https://www.ncbi.nlm.nih.gov/pubmed/30925872 http://dx.doi.org/10.1186/s12905-019-0748-8 |
Ejemplares similares
-
Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis
por: Yano, Junko, et al.
Publicado: (2017) -
Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome
por: Bruno, Vincent M., et al.
Publicado: (2015) -
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
por: Goje, Oluwatosin, et al.
Publicado: (2023) -
Reply to “Chronic Vaginal Candidiasis Is Achievable in Outbred CD-1 Mice”
por: Yano, Junko, et al.
Publicado: (2017) -
Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)